User:Mr. Ibrahem/Dexrazoxane

Dexrazoxane, sold under the brand name Zinecard among others, is a medication used to prevent cardiomyopathy due to doxorubicin and in extravasation of anthracyclines. It is given by injection into a vein.

Common side effects include pain at the site of injection, nausea, and diarrhea. Other side effects may include bone marrow suppression. In children in may increase the risk of further cancers. It is an antidote to anthracyclines.

Dexrazoxane was discovered in 1972. It was approved for medical use in the United States in 1995 and Europe in 2006. In the United States 500 mg costs about 420 USD as of 2021. This amount in the United Kingdom is about £160.